Brought to you by 
Novostia raises CHF6.5mm via seed round
25 Feb 2019
Executive Summary
Novostia SA raised CHF6.5mm ($6.5mm) in its seed financing to undisclosed private investors. The company will use the proceeds to move its disruptive aortic and mitral heart valve into the clinic. Its valve incorporates a biocompatible polymer, is more durable, and doesn’t require that patients take life-long anticoagulants as is the case with other valve technologies.
Deal Industry
- Biotechnology
- Medical Devices
-
Medical Devices
- Biomaterials
- Implantable Devices
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Novostia raises CHF6.5mm via seed round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice